PATIENT HISTORY: '

CHIEF COMPLAINTI PRE-OPI POST-OP DIAGNOSIS: Leﬂ breast cancer.

LMP DATE. Not applicable.

MILD—3

Cm,“ \W, ”2/“ IW’Vf W W 5750:1/3
641,- WINE} c501 A! 3/)y/H

PROCEDURE; Len segmentai mastadomy with wire Iocalizaiion. seminal node biopsy and mapping.
SPECIFIC CLINICAL QUESTION: Not provided.

OUTSIDE TISSUE DIAGNOSIS. No.

PRIOR MALIGNANCY: No.

CHEMORADIATION THERAPY No.

OTHER DISEASES: No

FINAL DIAGNOSIS: ’ “"memmm
PART 1: LYMPH NODE. LEFT AXILLA. SENTINEL MODE #1, BIOPSY -
ONE BENIGN LYMPH NODE. NO EVIDENcE OF MALIGNANCY Ion).

PART 2: LYMPH MODE, LEFT AXILLA. SENTINEL MODE #2. BIOPSY -
ONE BENIGN LYMPH MODE. NO EVIDENCE OF MALIGNANCY (011).

PART 3: BREAST, LEFT. SEGMENTAL NASTEcTONv WITH WIRE LOCALIZATION -
A. INVASIVE DucTAL cARcINouA, NOTTINGNAAI GRADE 2 (TUBULAR FORMATION: a. nucLEAR
pLEONORPHIsu: 2. MITOTIC ACTIVITY: 2; TOTAL SCORE m}.
INVASIVE TUMOR MEASURES 1.5 CM IN GREATEST DIMENSION (GROSS HEASU REMENT).
LVNPNOVAchLAR SPACE INVASION Is pREaENT.
DUCTAL CARCINOMA IN~SITU (DCIS). NUCLEAR GRADE 2. SOLID TYPE»

_,REsEOTION IIARGINs ARE NEGATIVE FOR OARcINONA; cARcINOMA Is 2 III" FRONT NEAREST
JANIERIOBLMAFGIHJ' “BET ~ ‘ - '- . - w ‘ m.» -.A.. «A u- my.— .. and.— .c‘ - ' " ., ‘ . -' v 'ﬂaﬁx'ﬁ'ﬁ‘gykz ~1~n.*--“.3A‘-«
FIEROCYETTO CHANsEs; DUCTAL EPITI-IELIAI: WE‘RE-WA Rﬁb sccE’RﬁéIﬁﬁ‘Rb I .' " ' ' " '

BIOPSY SITE CHANGES.
CALCIFICATIONS AssocIATEo wm-I BENIGN AND NALIONANT AREAs.
TUMOR REPORTED TO BE POSITIVE FOR ER AND PR. AND NEGATIVE FOR HER-wNEu

3.0.1? Inpmn

J. I'AIHOLOGIC STAGE: pTia pND.
SYNOPTIC - PRIMARY INVASIVE CARCIN
:ATERALITY: MONA OF BREAST
ROCEDURE: Sagmentai
LOCATION: Clock posmon:12:00

SIZE OF TUMOR: Maximum dimensio i ' ponen '
MULTICENTRICITYIMULTIFOCALITY OF INVASIVE FOGI:I rwaswe min t 15 mm
No
TUMOR TYPE (invasive component}:
Ductal adenpggrginoma, NOS
Nuclear grade: 2
Tubuie forrna‘ﬂon: 3
Mitotic activity score: 2
mm Nottingham score: 7
u’ .
_ ANGIOLYMPI-IAIIO INVAsION: Yes Wham grade (1' 2' 3" 2
DERuAL LYMPHATIG INVASION." ' ‘ NOf applimbi?“ " '" ""' ' '
CALCIFICATION: Yes, benign zones
Yo . ’
TUMOR TYPE. IN SITU: sozdmallgnant 20"”
Percent of tumor OOOu ‘ ‘ ’ '
SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT? by m SIIu mmponen‘l. 10 %
NO

DiaIa f ' ' .
suns MARGINs INVOLVED BY IN srru confpgugﬁﬁva tummo don't mug” 3 m

No
LYMPH NDDEs POSITIVE: 3'3““ °f '" 5"” disease to claw margin: 2 mm
LYMPH NODEs EXAMINED: 2

METHOIRS) OF LYMPH NODE EXAMINATION:

HIE I ‘
T STAGE. PATHOLOGIC: pTIas m

N STAGE MODIFIER: (3n)
' . . - FIE-r1572ac1AAEs
N STAGE. PATHOLOGIC. pm UUID:6AE92F5F “33113523“ Redacted

M STAGE- ~ TcGA—BH-A ‘

ESTROGEN mamas: Siéiﬁfi'ﬁi’iw 205 III IIIIIIIIIIIIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII

:noeesrgnona necemns: gas-Ive: Mm: 225 IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIII
Em" ’ IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIuIquuuuIIIIIIII

NOTTINGHAM SCORE:

4-qu,—§oai~1.arrmi --. -".r°:“4!-'-r“:'.‘r| ET in .':~."h"'. “‘v- -'

    
 

oi nods Dimepancv _
PrimI TurnoI Site Discrepancy

  

